Investment List

37 investments found

Date	Investor	Investor*	Target	Round	Group	Amount (USD)	Country
2023-12-05	OrbiMed	OrbiMed	Odyssey Therapeutics	Series C	4 Growth	—
2023-11-15	OrbiMed	OrbiMed	Koya Medical	Series C	4 Growth	—
2023-11-02	OrbiMed	OrbiMed	Terremoto Biosciences	Series B	3 Early Growth	—
2023-10-31	OrbiMed	OrbiMed	Forward Therapeutics	Series A	3 Early Growth	—
2023-10-26	OrbiMed	OrbiMed	Triveni Bio	Series A	3 Early Growth	—
2023-10-24	OrbiMed	OrbiMed	Rampart Bioscience	Series A	3 Early Growth	—
2023-10-19	OrbiMed	OrbiMed	Angitia Biopharmaceuticals	Series B	3 Early Growth	—
2023-10-18	OrbiMed	OrbiMed	Avita Medical	Post-IPO Debt	6 Exit / Public	—
2023-10-11	OrbiMed	OrbiMed	Minervax	Venture Round	7 Other	—
2023-10-09	OrbiMed	OrbiMed	Sirius Therapeutics	Series B	3 Early Growth	—
2023-10-03	OrbiMed	OrbiMed	Iambic	Series B	3 Early Growth	—
2023-09-27	OrbiMed	OrbiMed	Evozyne	Series B	3 Early Growth	—
2023-09-25	OrbiMed	OrbiMed	Adela	Series A	3 Early Growth	—
2023-09-19	OrbiMed	OrbiMed	ReCode Therapeutics	Series B	3 Early Growth	—
2023-09-07	OrbiMed	OrbiMed	Corteria Pharmaceuticals	Series A	3 Early Growth	—
2023-09-05	OrbiMed	OrbiMed	Star Therapeutics	Series C	4 Growth	—
2023-08-29	OrbiMed	OrbiMed	Epigenic Therapeutics	Series A	3 Early Growth	—
2023-08-23	OrbiMed	OrbiMed	Fore Biotherapeutics	Series D	4 Growth	—
2023-08-17	OrbiMed	OrbiMed	Valneva	Post-IPO Debt	6 Exit / Public	—
2023-08-09	OrbiMed	OrbiMed	ADARx Pharmaceuticals	Series C	4 Growth	—
2023-08-07	OrbiMed	OrbiMed	Gracell Biotechnologies	Post-IPO Equity	6 Exit / Public	—
2023-06-09	OrbiMed	OrbiMed	Vicore Pharma	Post-IPO Equity	6 Exit / Public	—
2023-06-08	OrbiMed	OrbiMed	Upstream Bio	Series B	3 Early Growth	—
2023-05-15	OrbiMed	OrbiMed	InspireMD	Post-IPO Equity	6 Exit / Public	—
2023-05-03	OrbiMed	OrbiMed	Magenta Medical	Venture Round	7 Other	—
2023-05-03	OrbiMed	OrbiMed	Convergent Therapeutics	Series A	3 Early Growth	—
2023-04-13	OrbiMed	OrbiMed	Aer Therapeutics	Series A	3 Early Growth	—
2023-03-27	OrbiMed	OrbiMed	Harpoon Therapeutics	Post-IPO Equity	6 Exit / Public	—
2023-03-06	OrbiMed	OrbiMed	Congruence Therapeutics	Series A	3 Early Growth	—
2023-03-01	OrbiMed	OrbiMed	TandemAI	Series A	3 Early Growth	—
2023-02-22	OrbiMed	OrbiMed	BIOMx	Post-IPO Equity	6 Exit / Public	—
2023-02-14	OrbiMed	OrbiMed	Disc Medicine	Post-IPO Equity	6 Exit / Public	—
2023-02-07	OrbiMed	OrbiMed	Garuda Therapeutics	Series B	3 Early Growth	—
2023-01-20	OrbiMed	OrbiMed	ADARx Pharmaceuticals	Series B	3 Early Growth	—
2023-01-19	OrbiMed	OrbiMed	Caris Life Sciences	Debt Financing	7 Other	—
2023-01-18	OrbiMed	OrbiMed	Pathalys Pharma	Series A	3 Early Growth	—
2023-01-06	OrbiMed	OrbiMed	Amolyt Pharma	Series C	4 Growth	—	FR